{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cows-milk-allergy-in-children/prescribing-information/antihistamines/","result":{"pageContext":{"chapter":{"id":"dec41209-5401-5f94-b2d8-acdbcc570995","slug":"antihistamines","fullItemName":"Antihistamines","depth":2,"htmlHeader":"<!-- begin field 23a74893-418e-425f-bcd7-ab1200f7f993 --><h2>Antihistamines</h2><!-- end field 23a74893-418e-425f-bcd7-ab1200f7f993 -->","summary":"","htmlStringContent":"<!-- begin item 431357de-5e66-4963-bd15-ab1200f7f97b --><!-- end item 431357de-5e66-4963-bd15-ab1200f7f97b -->","topic":{"id":"a5282e12-9e0e-5a93-bf1e-c47cb44993b6","topicId":"055e8853-0668-4ee8-bef5-d86e8a39b416","topicName":"Cow's milk allergy in children","slug":"cows-milk-allergy-in-children","lastRevised":"Last revised in December 2019","chapters":[{"id":"e95ad3f8-8ddd-57bd-8fe1-a01a59402ca1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"fceefe8b-f1a1-54cb-add7-5660134a61f9","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"ff117841-0d0c-5d1f-ad22-a2d8db741006","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0a17cde7-a3cc-580f-a5ec-e74a03694b87","slug":"changes","fullItemName":"Changes"},{"id":"e8251ee6-b8da-567a-b543-5efa4c24f074","slug":"update","fullItemName":"Update"}]},{"id":"5cd1ea49-3964-5480-beb5-1208ab83ecb4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6737a350-b49d-5d33-a999-d2a5f41c7f48","slug":"goals","fullItemName":"Goals"},{"id":"bb1f8ca2-c855-56ee-bc57-4b1b77c9a276","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"296bbdac-c210-5305-8b31-aabc917df09f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5c4984e6-3f82-5632-9d43-2766ecbdec62","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"52bb5ec1-cd13-5a6e-a889-5e1d7a9ffcf6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"92a5493f-38a6-5d89-a3e6-bcf0d7bfa1d6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8bb88e63-0cf4-5025-8dd3-1041e3b9d9ea","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ec87042d-84e0-5a22-97eb-f9c346e5f3de","slug":"definition","fullItemName":"Definition"},{"id":"62433689-0bf5-54f1-a4c2-61d6274cdd19","slug":"causes","fullItemName":"Causes"},{"id":"99c10d89-9bd7-5a68-ba37-37973a5b10d4","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8ef82df6-42bc-5a14-9b57-254620a2b8aa","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"986684f6-12eb-5097-b456-a4a93d13e8df","slug":"complications","fullItemName":"Complications"},{"id":"be406e14-2076-5909-8906-48b6811961c8","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"25997383-2b89-5120-b436-f78f553f71a5","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"40d0f3d9-d912-537d-87c5-b3640e611d04","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2ebab214-a599-539f-ae72-55b67692fa41","slug":"assessment","fullItemName":"Assessment"},{"id":"586d5e98-ed70-5f18-87b4-4725205a7deb","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"76847d5d-24bd-5dc8-9e92-c6b0890604de","fullItemName":"Management","slug":"management","subChapters":[{"id":"3b931251-98f4-5554-b841-9a3066fb9d2a","slug":"suspected-cows-milk-allergy","fullItemName":"Scenario: Suspected cow's milk allergy"},{"id":"c08df731-7d31-540e-b7dd-58b4606316cc","slug":"confirmed-non-ige-mediated-cows-milk-allergy","fullItemName":"Scenario: Confirmed non-IgE-mediated cow's milk allergy"}]},{"id":"c9a37070-6475-56bf-b6e4-a4b75bdcb888","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"dec41209-5401-5f94-b2d8-acdbcc570995","slug":"antihistamines","fullItemName":"Antihistamines"}]},{"id":"582c6a43-d7ef-548b-bdef-e89a48b4d00c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"998056ba-a465-5255-ad48-11dce2f00add","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2ff6786c-3e69-5e28-b3e1-65b80a6e4dff","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b656a2b3-ec81-5ad9-bada-358c550dcb41","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a22b091c-0a22-5881-8f67-ef85da859ab7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"af6d7d62-42c6-5ce2-be6c-f07386664122","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2769d864-70a1-54c7-a684-6d21c7f45b79","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"24227540-66cf-5a28-ac25-cf52ba9aad4e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"c9a37070-6475-56bf-b6e4-a4b75bdcb888","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"b516414c-916a-5766-a4df-83d8f5264f93","slug":"dose-regimens","fullItemName":"Dose regimens","depth":3,"htmlHeader":"<!-- begin field 3cc2d8c3-bd34-406d-aadd-ab1200f8c1c3 --><h3>Dose regimens</h3><!-- end field 3cc2d8c3-bd34-406d-aadd-ab1200f8c1c3 -->","summary":"","htmlStringContent":"<!-- begin item 94649b8c-f7dd-48ac-add2-ab1200f8c1a3 --><!-- begin field 3a9ec268-4234-4156-9fff-ab1200f8c1c3 --><ul><li><strong>Chlorphenamine maleate syrup is not licensed for use in children under 1 year of age.</strong> A suggested dose regimen is:<ul><li>Children aged 1–23 months — 1 mg twice daily.</li></ul></li><li><strong>Cetirizine hydrochloride is not licensed for use in children under 2 years of age.</strong> A suggested dose regimen is:<ul><li>Children aged 1 year — 250 micrograms/kg twice daily (off-label).</li><li>Children aged 2–5 years — 2.5 mg twice daily.</li><li>Children aged 6–11 years — 5 mg twice daily.</li><li>Children aged 12 and over, and adults — 10 mg once daily.</li></ul></li><li><strong>Loratadine is not licensed for use in children under 2 years of age.</strong> A suggested dose regimen is:<ul><li>Children aged 2–11 years and body weight up to 31 kg — 5 mg once a day.</li><li>Children aged 2–11 years and body weight 31 kg and over — 10 mg once a day.</li><li>Children aged 12 years and over, and adults — 10 mg once a day.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019b</a>]  </p><!-- end field 3a9ec268-4234-4156-9fff-ab1200f8c1c3 --><!-- end item 94649b8c-f7dd-48ac-add2-ab1200f8c1a3 -->","subChapters":[]},{"id":"5b4bbf04-217a-5882-9cea-6fde30c974af","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 1fe9b0d5-07ef-4d2b-a5b9-ab1200f897e4 --><h3>Contraindications and cautions</h3><!-- end field 1fe9b0d5-07ef-4d2b-a5b9-ab1200f897e4 -->","summary":"","htmlStringContent":"<!-- begin item 03e32ff4-5072-4bbe-acec-ab1200f897c8 --><!-- begin field 1e506def-9e8a-49fe-929e-ab1200f897e4 --><ul><li><strong>Do not prescribe cetirizine to people with:</strong><ul><li>Severe renal impairment — estimated glomerular filtration rate (eGFR) less than 10 mL/min/1.73 m<sup>2</sup>.</li></ul></li><li><strong>Prescribe chlorphenamine with caution to people with:</strong><ul><li>Epilepsy.</li><li>Prostatic hypertrophy.</li><li>Pyloroduodenal obstruction.</li><li>Susceptibility to angle-closure glaucoma.</li><li>Urinary retention.</li></ul></li><li><strong>Prescribe cetirizine with caution to people with:</strong><ul><li>Epilepsy.</li><li>Renal impairment<ul><li>If the eGFR is 30–50 mL/min/1.73 m<sup>2</sup>, use half the normal dose.</li><li>If the eGFR is 10–30 mL/min/1.73 m<sup>2</sup>, use half the normal dose and reduce the dose frequency to alternate days.</li></ul></li></ul></li><li><strong>Prescribe loratadine with caution to people with:</strong> <ul><li>Severe hepatic impairment — reduce the dose frequency to alternate days.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019b</a>]</p><!-- end field 1e506def-9e8a-49fe-929e-ab1200f897e4 --><!-- end item 03e32ff4-5072-4bbe-acec-ab1200f897c8 -->","subChapters":[]},{"id":"befb7dd1-1816-5d04-95df-7a60ba9cd142","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field c3859855-a51d-47f0-abe3-ab1200f8b4a0 --><h3>Adverse effects</h3><!-- end field c3859855-a51d-47f0-abe3-ab1200f8b4a0 -->","summary":"","htmlStringContent":"<!-- begin item 041d36ee-2418-46e9-93f0-ab1200f8b487 --><!-- begin field fed31253-6dc4-438f-9a68-ab1200f8b4a0 --><ul><li><strong>Possible adverse effects of chlorphenamine, cetirizine, and loratadine include:</strong><ul><li>Blurred vision, dry mouth, headache, diarrhoea, psychomotor impairment, urinary retention.</li><li>Drowsiness (frequency not known) — cetirizine and loratadine cause less sedation and psychomotor impairment than first-generation antihistamines such as chlorphenamine, because they penetrate the blood brain barrier to a lesser extent.<ul><li>Advise people taking non-sedating antihistamines that some people may experience sedation, which may affect their ability to drive, and that the sedative effects are enhanced when combined with alcohol.</li></ul></li><li>Angio-oedema, arrhythmias, blood disorders, bronchospasm, confusion, convulsions, depression, dizziness, extrapyramidal effects, hypersensitivity reactions, hypotension, liver dysfunction, photosensitivity reactions, rashes, sleep disturbances, tremor, angle-closure glaucoma (in adults).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019b</a>]</p><!-- end field fed31253-6dc4-438f-9a68-ab1200f8b4a0 --><!-- end item 041d36ee-2418-46e9-93f0-ab1200f8b487 -->","subChapters":[]},{"id":"899aec5a-36a2-578c-8dd6-0693eba132fd","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field f6d25d73-e864-4837-8852-ab1200f8a5e1 --><h3>Drug interactions</h3><!-- end field f6d25d73-e864-4837-8852-ab1200f8a5e1 -->","summary":"","htmlStringContent":"<!-- begin item d446bd56-c1e8-43ab-89e5-ab1200f8a5ca --><!-- begin field 7c4cdbcf-49a8-4ecf-9970-ab1200f8a5e1 --><ul><li><p><strong>Possible drug interactions with cetirizine and loratadine include:</strong></p><ul><li><strong>Betahistine</strong> — cetirizine and loratadine are predicted to decrease the effects of betahistine.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/cows-milk-allergy-in-children/references/\">Joint Formulary Committee, 2019b</a>]</p><!-- end field 7c4cdbcf-49a8-4ecf-9970-ab1200f8a5e1 --><!-- end item d446bd56-c1e8-43ab-89e5-ab1200f8a5ca -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}